Filament Health Corp. (TSE:FH) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Filament Health Corp. has announced a robust expansion of its intellectual property portfolio with 20 new patents in the US, Canada, and Australia, reinforcing its position in the psychedelic drug market. Despite operational cash outflows, the company remains optimistic about its financial prospects with total revenues reaching $426,661 in the third quarter of 2024.
For further insights into TSE:FH stock, check out TipRanks’ Stock Analysis page.
